By 2030, it is anticipated that the Kenya infectious disease therapeutics market will reach a value of $128.3 Mn from $83.9 Mn in 2022, growing at a CAGR of 5.5% during 2022-2030. The Infectious Disease Therapeutics in Kenya is dominated by a few domestic pharmaceutical companies such as Kenya Medical Research Institute, Bio-Ken and Kenya Vaccines and Immunizations Institute. The Infectious Disease Therapeutics market in Kenya is segmented into different therapeutic areas and different diseases type. The major factors affecting the Kenya infectious disease therapeutics market are the increasing disease burden of communicable diseases like TB, hepatitis, COVID-19, and the amount of healthcare funding for infectious diseases treatment in various areas of Kenya.
By 2030, it is anticipated that the Kenya infectious disease therapeutics market will reach a value of $128.3 Mn from $83.9 Mn in 2022, growing at a CAGR of 5.5% during 2022-2030.
Kenya is a lower middle-income, developing country in Eastern Africa bordering the Indian Ocean and Lake Victoria. According to the World Factbook, Kenya is extremely vulnerable to the infectious diseases listed below. Food or waterborne infections include bacterial and protozoal diarrhoea, hepatitis A, and typhoid fever. In Kenya, infectious diseases caused by water contact, such as schistosomiasis, are common. Rabies, malaria, dengue fever, and Rift Valley fever are among the major infectious diseases in Kenya.
Kenya has a rising pharmaceutical sector in terms of medicine use. According to Kenya Pharmaceutical Association research, the Kenyan pharmaceutical market is expected to be worth $830 Mn in 2020, with medications for infectious diseases being one of the most important therapeutic categories. Kenya's government spends 4.6% of its GDP on healthcare.
Market Growth Drivers Analysis
Kenya has been fighting malaria by improving access to diagnostic tools and producing new treatments. Kenya is continuing to implement the president's Big Four Agenda, which focuses on food security, manufacturing employment, universal and inexpensive health care, and affordable housing. Kenya has a rapidly rising population and a developing middle class. These aspects could boost Kenya's infectious disease therapeutics market.
Market Restraints
Developing new pharmaceuticals and treatments necessitates adherence to regulatory rules established by organisations such as Kenya's Pharmacy and Poisons Board (PPB). These requirements can be complicated and time-consuming, resulting in delays and higher expenses. Kenya suffers recurrent constraints due to a lack of infrastructure and a paucity of skilled workers. These factors may deter new entrants into the Kenya infectious disease therapeutics market.
Key Players
July 2022: Tonix Pharmaceuticals, a clinical-stage biopharmaceutical firm, announced a partnership with the Kenya Medical Research Institute (KEMRI) to organise, obtain regulatory clearance for, and potentially perform a Phase 1 clinical study in Kenya to develop TNX-8011 as a monkeypox vaccine. Tonix and KEMRI will collaborate to get regulatory approval in Kenya in order to begin Phase 1 clinical research of TNX-801. The research is set to begin in the first half of 2023.
The Pharmacy and Poisons Board oversees the regulation of infectious disease medicines in Kenya (PPB). The National Hospital Insurance Fund (NHIF) is in charge of overseeing the national health insurance programme, which covers a variety of healthcare services, including pharmaceuticals and infectious disease treatments.
1. Report Description of the Kenya Infectious Disease Therapeutics
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. Kenya Infectious Disease Therapeutics Executive Summary
2.1 Kenya Infectious Disease Therapeutics – Industry Snapshot & key buying criteria, 2021-2030
2.2 Market Size, Growth Prospects, and Key findings
3. Market Dynamics of Kenya Infectious Disease Therapeutics
3.1 Market Growth Drivers Analysis
3.2 Market Restrains Analysis
4. Kenya Infectious Disease Therapeutics Segmentation
4.1 By Mode of Treatment
4.1.1 Vaccines
4.1.2 Drugs
4.2 By Applications
4.2.1 HIV/AIDS
4.2.2 Influenza
4.2.3 Hepatitis
4.2.4 Malaria
4.2.5 Tuberculosis
4.2.6 Others
4.3 By Disease Type
4.3.1 Viral Diseases
4.3.2 Bacterial Diseases
4.3.3 Fungal Diseases
4.3.4 Parasitic Diseases
4.3.5 Others
4.4 By Target Organism
4.4.1 Antibiotics
4.4.2 Antivirals
4.4.3 Antifungals
4.4.4 Anti-Parasitic
4.4.5 Others
4.5 By End User
4.5.1 Hospitals and Clinics
4.5.2 Ambulatory Care Centers
4.5.3 Others
5. Kenya Infectious Disease Therapeutics Share
5.1 Market Analysis, Insights, and Forecast – By Revenue
6. Competitive Landscape
6.1 Major Top Market Players
7. Key Company Profiles
7.1 Company 1
7.1.1 Overview
7.1.2 Financial Performance
7.1.3 Product & Services
7.1.4 Strategic initiatives
7.2 Company 2
7.2.1 Overview
7.2.2 Financial Performance
7.2.3 Product & Services
7.2.4 Strategic initiatives
7.3 Company 3
7.3.1 Overview
7.3.2 Financial Performance
7.3.3 Product & Services
7.3.4 Strategic initiatives
7.4 Company 4
7.4.1 Overview
7.4.2 Financial Performance
7.4.3 Product & Services
7.4.4 Strategic initiatives
7.5 Company 5
7.5.1 Overview
7.5.2 Financial Performance
7.5.3 Product & Services
7.5.4 Strategic initiatives
8. Healthcare Policies and Regulatory Landscape
8.1 Healthcare Policies in Kenya
8.2 Regulatory Framework in Kenya
8.3 Pricing & Reimbursement Scenario in Kenya Infectious Disease Therapeutics
9. Factors Driving Future Growth
9.1 New Trends and Development Kenya Infectious Disease Therapeutics
9.2 Future Opportunities
10. Strategic Recommendations
By Mode of Treatment (Revenue, USD Billion):
By Applications (Revenue, USD Billion):
By Disease Type (Revenue, USD Billion):
By Target Organism (Revenue, USD Billion):
By End User (Revenue, USD Billion):
Insights10 will provide you with the reports within 10 key parameters which are:
Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.
Stage I: Market Data Collection
Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.
Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.
Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:
Stage II: Market Data Analysis and Statistical Model
Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.
Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.
The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.
The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.
Data Triangulation & Validation:
Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.
We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.
Stage III: Interpretation and Presentation
Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)
Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.
Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.
This report addresses
Need more?